CRISPR Therapeutics


CRISPR Therapeutics
$34.83 $0.64 1.9%
BATS BZX Real Time Price as of March 26, 2019, 4:00 p.m. View Interactive CRSP Charts

CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.

News & Analysis: CRISPR Therapeutics

The Fool has written over 100 articles on CRISPR Therapeutics.
Market Moves

5 Top Gene-Editing Stocks for 2019

The future of treating disease might be gene editing, and these five stocks have the most promising technologies.

Interactive Chart